Tel Aviv University

University / College


Location: Tel Aviv, Israel (IL) IL

ISNI: 0000000419370546

ROR: https://ror.org/04mhzgx49

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Reactive astrocyte nomenclature, definitions, and future directions (2021) Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhäuser C, et al. Journal article, Review article Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? (2021) Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T, Lopes MB, Kunz P, et al. Journal article Shaping of Electron Beams Using Sculpted Thin Films (2021) Roitman D, Shiloh R, Lu PH, Dunin-Borkowski RE, Arie A Journal article Transcriptional response of Aspergillus fumigatus to copper and the role of the Cu chaperones (2021) Anabosi D, Meir Z, Shadkchan Y, Handelman M, Abou-Kandil A, Yap A, Urlings D, et al. Journal article #EEGManyLabs: Investigating the replicability of influential EEG experiments (2021) Pavlov YG, Adamian N, Appelhoff S, Arvaneh M, Benwell CS, Beste C, Bland AR, et al. Journal article Filling of small oval root canals: influence of sealer placement and filling technique (2021) Schunemann FH, Canani SH, Lohbauer U, Petschelt A, Metzger Z, Ebert J Journal article DLG4-related synaptopathy: a new rare brain disorder (2021) Rodriguez-Palmero A, Boerrigter MM, Gomez-Andres D, Aldinger KA, Marcos-Alcalde I, Popp B, Everman DB, et al. Journal article SCAF4 loss of function in humans and Drosophila implicates mRNA transcriptional termination in neuro-developmental disorders (2020) Fliedner A, Kirchner P, Agre KE, De Graaf-Van De Laar I, Clarke MD, Davis-Keppen L, Ekici AB, et al. Conference contribution 11. The Moral Economy of Brujería under the Modern Colony: A Pirated Modernity? (2020) Romberg R Book chapter / Article in edited volumes Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article